Menu
Contact Us
Subscribe
Menu

Sample Post Title!

By Author Name
3 min. read

Morbi libero lectus, laoreet elementum viverra vitae, sodales sit amet nisi. Vivamus dolor ipsum, ultrices in accumsan nec, viverra in nulla.

Donec ligula sem, dignissim quis purus a, ultricies lacinia lectus. Aenean scelerisque, justo ac varius viverra, nisl arcu accumsan elit, quis laoreet metus ipsum vitae sem. Phasellus luctus imperdiet.

Donec tortor ipsum

Pharetra ac malesuada in, sagittis ac nibh. Praesent mattis ullamcorper metus, imperdiet convallis eros bibendum nec. Praesent justo quam, sodales eu dui vel, iaculis feugiat nunc.

Pellentesque faucibus orci at lorem viverra, id venenatis justo pretium. Nullam congue, arcu a molestie bibendum, sem orci lacinia dolor, ut congue dolor justo a odio.

Duis odio neque, congue ut iaculis nec, pretium vitae libero. Cras eros ipsum, eleifend rhoncus quam at, euismod sollicitudin erat.

Fusce imperdiet, neque ut sodales dignissim, nulla dui. Nam vel tortor orci.

More technical briefs

The Role of Activism in Shaping Law and Policies that Support Access to Medicines

Ellen 't Hoen -
This article is also available as a PDF here. Almost 26 years ago, here in Amsterdam, on November 25-26, 1999, Health Action International, Médecins Sans...

Transfer of technology and know-how for the production of pandemic-related health products in the WHO Pandemic Agreement: The proverbial half glass 

Ellen 't Hoen -
A version of this brief was published on 13 June '25 by the Graduate Institute as part of their 'Governing Pandemic Snapshot' series: https://www.governingpandemics.org/gp-snapshot During...

Pharmaceutical patents and data exclusivity in an age of AI-driven drug discovery and development

Christopher Garrison -
This is an excerpt from a longer report on AI, medicines development and the patent system. Download the full report here (or by clicking...

Continuing to ignore the problem of the know-how gap won’t make it go away.

Christopher Garrison -
The Covid-19 pandemic was a wake-up call for a variety of issues in access to medicines, one of which was finding a solution to...
Load more

Related Articles

The Role of Activism in Shaping Law and Policies that Support Access to Medicines

Ellen 't Hoen -
This article is also available as a PDF here. Almost 26 years ago, here in Amsterdam, on November 25-26, 1999, Health Action International, Médecins Sans...

Affordability, binding commitments to technology sharing, and transparency key in Pathogen Access and Benefit Sharing

Ellen 't Hoen -
We appreciate the opportunity to offer comments on the draft PABS annex text . Some preliminary comments: Affordability of Access: The current draft mentions "providing access...

Generic versions of a lifesaving cystic fibrosis treatment will save patients $360,000 a year – expanding access and prolonging lives

Kaitlin Mara -
Generic versions of a cystic fibrosis treatment will now be available at $6,375 per child, per year under a new scheme – offering hope...

The IGWG process offers an opportunity to fulfil the equity objectives of the Pandemic Agreement

Ellen 't Hoen -
Co-Chairs,  Thank you for the opportunity to make a brief intervention. Both the sharing of pathogens and the sharing of the benefits, including products and knowledge,...
Load more

Newsletter

Never miss a post! Sign up for ML&P's newsletter.

Recent Articles

The Role of Activism in Shaping Law and Policies that Support Access to Medicines

Ellen 't Hoen -
This article is also available as a PDF here. Almost 26 years ago, here in Amsterdam, on November 25-26, 1999, Health Action International, Médecins Sans...

Generic versions of a lifesaving cystic fibrosis treatment will save patients $360,000 a year – expanding access and prolonging lives

Kaitlin Mara -
Generic versions of a cystic fibrosis treatment will now be available at $6,375 per child, per year under a new scheme – offering hope...

WHO Members meet to finalise the Pathogen Access and Benefit Sharing Instrument

Ellen 't Hoen -
In May 2025, the WHO member states adopted the Pandemic Agreement, but they left the work to establish an instrument for Pathogen Access and...

FDA approval of injectable lenacapavir for Pre-Exposure Prophylaxis (PrEP) opens the road to ending HIV

Ellen 't Hoen -
On 18th June 2025, the US Food and Drug Administration (FDA) approved the use of long-acting antiretroviral medicine lenacapavir (LEN-LA), for the prevention of...

Transfer of technology and know-how for the production of pandemic-related health products in the WHO Pandemic Agreement: The proverbial half glass 

Ellen 't Hoen -
A version of this brief was published on 13 June '25 by the Graduate Institute as part of their 'Governing Pandemic Snapshot' series: https://www.governingpandemics.org/gp-snapshot During...
Load more

Medicines Law & Policy

Medicines Law & Policy releases analysis, policy recommendations and tools to aid practitioners working on universal access to medicines. We strive to provide information that is as accurate as possible, and we welcome and encourage feedback. For comments or questions contact us at: office@medicineslawandpolicy.net.

Never miss a post! Sign up for ML&P's newsletter.

This work is licensed under Creative Commons. You are free to share, with attribution and without changes, for non-commercial purposes.